Inspire Medical Systems Inc [INSP] stock is trading at $81.79, down -2.41%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The INSP shares have gain 13.47% over the last week, with a monthly amount glided 2.06%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on November 04, 2025, when Wells Fargo upgraded its rating to a Overweight but kept the price target unchanged to $90 for it. Previously, Jefferies downgraded its rating to Hold on October 24, 2025, and kept the price target unchanged to $85. On September 22, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $89 on the stock. Evercore ISI started tracking the stock assigning a Outperform rating and suggested a price target of $150 on September 02, 2025. Truist downgraded its rating to a Hold but $125 remained the price target by the analyst firm on August 05, 2025. KeyBanc Capital Markets downgraded its rating to Sector Weight for this stock on August 05, 2025. In a note dated August 05, 2025, JP Morgan downgraded an Neutral rating on this stock but restated the target price of $110.
Inspire Medical Systems Inc [INSP] stock has fluctuated between $70.77 and $216.01 over the past year. Currently, Wall Street analysts expect the stock to reach $115.44 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $81.79 at the most recent close of the market. An investor can expect a potential return of 41.14% based on the average INSP price forecast.
Analyzing the INSP fundamentals
Inspire Medical Systems Inc [NYSE:INSP] reported sales of 882.62M for the trailing twelve months, which represents a growth of 10.49%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.08 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 80.23 points at the first support level, and at 78.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 83.78, and for the 2nd resistance point, it is at 85.76.
Ratios To Look Out For
For context, Inspire Medical Systems Inc’s Current Ratio is 5.29. In addition, the Quick Ratio stands at 4.01 and the Cash Ratio stands at 1.15. Considering the valuation of this stock, the price to sales ratio is 2.69, the price to book ratio is 3.57 and price to earnings (TTM) ratio is 56.10.
Transactions by insiders
Recent insider trading involved Buchholz Richard, Chief Financial Officer, that happened on Aug 29 ’25 when 11000.0 shares were sold. Officer, Buchholz Richard completed a deal on Aug 29 ’25 to buy 11000.0 shares. Meanwhile, Rondoni John sold 1734.0 shares on May 19 ’25.
